Literature DB >> 30907249

MOG antibody-associated encephalomyelitis/encephalitis.

Sara Salama1, Majid Khan2, Santiago Pardo3, Izlem Izbudak2, Michael Levy4.   

Abstract

Myelin oligodendrocyte glycoprotein (MOG) antibody disease is a rare autoimmune disorder with antibodies against the MOG predominantly involving the optic nerve and spinal cord leading to vision loss and paralysis. When MOG antibody disease involves the brain, the phenotype is similar to acute disseminated encephalomyelitis (ADEM). In this review, we discuss MOG-positive cases presenting with encephalitis, encephalopathy, or ADEM-like presentation based on recently published series.

Entities:  

Keywords:  MOG antibody disease; MOG encephalomyelitis; MOG-EM; anti-MOG; myelin oligodendrocyte glycoprotein; optic neuritis; transverse myelitis

Mesh：

Substances：

Year:  2019        PMID： 30907249      PMCID： PMC6751007          DOI： 10.1177/1352458519837705

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  40 in total

1.  Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats.

Authors:  C Brunner; H Lassmann; T V Waehneldt; J M Matthieu; C Linington
Journal:  J Neurochem       Date:  1989-01       Impact factor: 5.372

2.  Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.

Authors:  Naomi Hino-Fukuyo; Kazuhiro Haginoya; Ichiro Nakashima; Douglas Kazutoshi Sato; Toshiyuki Takahashi; Tatsuro Misu; Kazuo Fujihara; Mieko Hirose; Yosuke Kakisaka; Mitsugu Uematsu; Tomoko Kobayashi; Shigeo Kure
Journal:  Brain Dev       Date:  2015-03-03       Impact factor: 1.961

3.  Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.

Authors:  Luana Michelli Oliveira; Samira Luisa Apóstolos-Pereira; Milena Sales Pitombeira; Pedro Henrique Bruel Torretta; Dagoberto Callegaro; Douglas Kazutoshi Sato
Journal:  Mult Scler       Date:  2018-11-12       Impact factor: 6.312

4.  Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.

Authors:  A K Pröbstel; K Dornmair; R Bittner; P Sperl; D Jenne; S Magalhaes; A Villalobos; C Breithaupt; R Weissert; U Jacob; M Krumbholz; T Kuempfel; A Blaschek; W Stark; J Gärtner; D Pohl; K Rostasy; F Weber; I Forne; M Khademi; T Olsson; F Brilot; E Tantsis; R C Dale; H Wekerle; R Hohlfeld; B Banwell; A Bar-Or; E Meinl; T Derfuss
Journal:  Neurology       Date:  2011-07-27       Impact factor: 9.910

5.  Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients.

Authors:  Silvia Tenembaum; Nestor Chamoles; Natalio Fejerman
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

6.  Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.

Authors:  Eva-Maria Hennes; Matthias Baumann; Kathrin Schanda; Banu Anlar; Barbara Bajer-Kornek; Astrid Blaschek; Sigrid Brantner-Inthaler; Katharina Diepold; Astrid Eisenkölbl; Thaddäus Gotwald; Georgi Kuchukhidze; Ursula Gruber-Sedlmayr; Martin Häusler; Romana Höftberger; Michael Karenfort; Andrea Klein; Johannes Koch; Verena Kraus; Christian Lechner; Steffen Leiz; Frank Leypoldt; Simone Mader; Klaus Marquard; Imke Poggenburg; Daniela Pohl; Martin Pritsch; Markus Raucherzauner; Mareike Schimmel; Charlotte Thiels; Daniel Tibussek; Silvia Vieker; Carolin Zeches; Thomas Berger; Markus Reindl; Kevin Rostásy
Journal:  Neurology       Date:  2017-08-02       Impact factor: 9.910

7.  Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

Authors:  Romana Höftberger; María Sepulveda; Thaís Armangue; Yolanda Blanco; Kevin Rostásy; Alvaro Cobo Calvo; Javier Olascoaga; Lluís Ramió-Torrentà; Markus Reindl; Julián Benito-León; Bonaventura Casanova; Georgina Arrambide; Lidia Sabater; Francesc Graus; Josep Dalmau; Albert Saiz
Journal:  Mult Scler       Date:  2014-10-24       Impact factor: 6.312

8.  Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

Authors:  Sung-Min Kim; Mark R Woodhall; Ji-Sun Kim; Seong-Joon Kim; Kyung Seok Park; Angela Vincent; Kwang-Woo Lee; Patrick Waters
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-10-15

9.  What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients.

Authors:  Shahd H M Hamid; Daniel Whittam; Kerry Mutch; Samantha Linaker; Tom Solomon; Kumar Das; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-08-24       Impact factor: 4.849

10.  Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Authors:  Maarten J Titulaer; Romana Höftberger; Takahiro Iizuka; Frank Leypoldt; Lindsey McCracken; Tania Cellucci; Leslie A Benson; Huidy Shu; Takashi Irioka; Makito Hirano; Gagandeep Singh; Alvaro Cobo Calvo; Kenichi Kaida; Pamela S Morales; Paul W Wirtz; Tomotaka Yamamoto; Markus Reindl; Myrna R Rosenfeld; Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Ann Neurol       Date:  2014-03       Impact factor: 10.422
View more
  17 in total

Review 1.  Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors:  Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2021-05-22       Impact factor: 2.447

2.  The immune signatures of multiple sclerosis: Lessons from twin studies.

Authors:  Pablo Villoslada; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

3.  Developing Consensus in the Assessment and Treatment Pathways for Autoimmune Encephalitis in Child and Adolescent Psychiatry.

Authors:  GenaLynne C Mooneyham; Vladimir Ferrafiat; Erin Stolte; D Catherine Fuchs; David Cohen
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

4.  Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.

Authors:  Stanislas Demuth; Maxime Guillaume; Bertrand Bourre; Jonathan Ciron; Hélène Zephir; Yoann Sirejacob; Anne Kerbrat; Christine Lebrun-Frenay; Caroline Papeix; Laure Michel; David Laplaud; Sandra Vukusic; Elisabeth Maillart; Mikael Cohen; Bertrand Audoin; Romain Marignier; Nicolas Collongues
Journal:  J Neuroinflammation       Date:  2022-03-02       Impact factor: 8.322

5.  Dimethyl fumarate mitigates optic neuritis.

Authors:  Katarzyna Zyla; Chelsea M Larabee; Constantin Georgescu; Chelsea Berkley; Tania Reyna; Scott M Plafker
Journal:  Mol Vis       Date:  2019-08-22       Impact factor: 2.367

6.  Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report.

Authors:  Pei Liu; Miao Bai; Xu Yan; Kaixi Ren; Jiaqi Ding; Daidi Zhao; Hongzeng Li; Yaping Yan; Jun Guo
Journal:  Ther Adv Neurol Disord       Date:  2020-10-29       Impact factor: 6.570

7.  MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report.

Authors:  Jordi Kühne Escolà; Cornelius Deuschl; Andreas Junker; Fabian Dusse; Refik Pul; Christoph Kleinschnitz; Martin Köhrmann; Benedikt Frank
Journal:  Ther Adv Neurol Disord       Date:  2022-01-19       Impact factor: 6.570

Review 8.  Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review.

Authors:  Michela Ada Noris Ferilli; Roberto Paparella; Ilaria Morandini; Laura Papetti; Lorenzo Figà Talamanca; Claudia Ruscitto; Fabiana Ursitti; Romina Moavero; Giorgia Sforza; Samuela Tarantino; Martina Proietti Checchi; Federico Vigevano; Massimiliano Valeriani
Journal:  Life (Basel)       Date:  2021-12-23

9.  Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies.

Authors:  Jingsi Wang; Zhandong Qiu; Dawei Li; Xixi Yang; Yan Ding; Lehong Gao; Aihua Liu; Yang Song; Cunjiang Li; Ran Gao; Lin Wang; Liyong Wu; Longfei Jia; Dongmei Guo; Aihong Zhou; Jianping Jia; Liyuan Huang; Miao Qu; Li Gao; Huiqing Dong; Junwei Hao; Zheng Liu
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

10.  Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.

Authors:  Silvia Messina; Romina Mariano; Adriana Roca-Fernandez; Ana Cavey; Maciej Jurynczyk; Maria Isabel Leite; Massimiliano Calabrese; Mark Jenkinson; Jacqueline Palace
Journal:  Mult Scler       Date:  2021-05-28       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.